Loading
IARC estimates 38,465 new cancer cases and 22,509 cancer deaths in Uzbekistan in 2024; the commonest new cancers are breast, colorectum and cervix uteri. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 4,793 | 26.0 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Colorectum | 3,586 | 10.6 | Colorectal cancer |
| Cervix uteri | 3,147 | 17.0 | Cervical cancer |
| Prostate | 3,042 | 23.0 | Prostate cancer |
| Stomach | 2,662 | 7.9 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 2,297 | 6.9 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Brain, central nervous system | 1,726 | 4.8 | Glioma & glioblastoma |
| Leukaemia | 1,510 | 4.2 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Liver and intrahepatic bile ducts | 1,507 | 4.6 | Hepatocellular carcinoma |
| Oesophagus | 1,377 | 4.2 | Oesophageal cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Stomach | 2,146 | 6.5 | Gastric & gastro-oesophageal junction cancer |
| Breast | 2,085 | 11.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 2,068 | 6.3 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Cervix uteri | 1,733 | 9.5 | Cervical cancer |
| Colorectum | 1,699 | 5.1 | Colorectal cancer |
| Liver and intrahepatic bile ducts | 1,437 | 4.4 | Hepatocellular carcinoma |
| Brain, central nervous system | 1,397 | 3.9 | Glioma & glioblastoma |
| Oesophagus | 1,258 | 3.9 | Oesophageal cancer |
| Pancreas | 1,079 | 3.3 | Pancreatic ductal adenocarcinoma |
| Leukaemia | 967 | 2.7 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
No trial record in OnCo lists a site in Uzbekistan. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Uzbekistan.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Uzbekistan is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
A deep dive for Uzbekistan is ranked 36 of 60 in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.